Shift in Stakeholder Engagement and Collaboration

One of the biggest changes in pharma launches after COVID was the shift in engagement with stakeholders. Due to quarantine measures, companies had to adapt to virtual meetings via platforms like Zoom and Teams. This required a mindset shift in collaboration and the use of new tools like Miro for online collaboration. The engagement planning strategies had to be reworked to accommodate remote work. While in-person engagements are slowly returning, the use of digital technology and omni-channel approaches have remained, making the commercialization process more efficient.